Transgene's nail biter

Therapeutic vaccine company Transgene S.A. will know by this Friday whether it will get a cash bolus representing about a year of cash or if it will have to go out on the road to raise more money.

Transgene (Euronext:Transgene, Strasbourg, France) has about 4.7 million warrants that will stop trading July 14, and expire July 17. If all are converted at the strike price of E8.05, the company would raise E18.7 million ($23.9 million) in new capital, which represents just under a year of cash at its current spend rate. ...